Safety and efficacy of nivolumab as a second line therapy in metastatic renal cell carcinoma: a retrospective chart review

AIM: To assess diseases outcomes and tolerability of real-life second-line nivolumab in a series of metastatic renal cell carcinoma (mRCC) patients. METHODS: This retrospective chart review involved prospectively monitored patients (named patient program) treated with second-line nivolumab for mRCC...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Croat Med J
Egile Nagusiak: Gamulin, Marija, Nham, Eric, Rkman, Deni, Antunac, Zrna, Golubić, Likić, Robert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Croatian Medical Schools 2020
Gaiak:
Resaerch Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7480755/
https://ncbi.nlm.nih.gov/pubmed/32881430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2020.61.326
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak